Working… Menu

A Study of Reolysin For Patients With Advanced/Metastatic Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01656538
Recruitment Status : Completed
First Posted : August 3, 2012
Last Update Posted : April 7, 2020
Oncolytics Biotech
Information provided by (Responsible Party):
Canadian Cancer Trials Group